These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1416181)

  • 21. Myotonias and masseter spasm: not malignant hyperthermia?
    Gronert GA
    Anesthesiology; 1995 Dec; 83(6):1382-3. PubMed ID: 8533946
    [No Abstract]   [Full Text] [Related]  

  • 22. Core myopathies and malignant hyperthermia susceptibility: a review.
    Brislin RP; Theroux MC
    Paediatr Anaesth; 2013 Sep; 23(9):834-41. PubMed ID: 23617272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postexercise muscle cramping associated with positive malignant hyperthermia contracture testing.
    Ogletree JW; Antognini JF; Gronert GA
    Am J Sports Med; 1996; 24(1):49-51. PubMed ID: 8638753
    [No Abstract]   [Full Text] [Related]  

  • 24. Masseter spasm after suxamethonium in children.
    Sims C
    Br J Hosp Med; 1992 Jan 23-Feb 4; 47(2):139-43. PubMed ID: 1543961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improper diagnostic test may account for high incidence of malignant hyperthermia associated with masseter spasm.
    Anesthesiology; 1986 Feb; 64(2):291-3. PubMed ID: 3946821
    [No Abstract]   [Full Text] [Related]  

  • 26. Masseter spasm following suxamethonium.
    Sinclair G
    Br J Hosp Med; 1990 Nov; 44(5):342. PubMed ID: 2275999
    [No Abstract]   [Full Text] [Related]  

  • 27. Assessment of masseter spasm complicated by a faulty temperature probe.
    Cohen JA; Winston RS
    J Clin Anesth; 1994; 6(6):521-4. PubMed ID: 7880518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Etiology of malignant hyperthermia].
    Okumura F; Kuro M
    Masui; 1975 Jun; 24(6):525-37. PubMed ID: 169408
    [No Abstract]   [Full Text] [Related]  

  • 29. Prediction of malignant hyperthermia susceptibility: statistical evaluation of clinical signs.
    Hackl W; Mauritz W; Schemper M; Winkler M; Sporn P; Steinbereithner K
    Br J Anaesth; 1990 Apr; 64(4):425-9. PubMed ID: 2334615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum creatine kinase screening for susceptibility to malignant hyperthermia.
    Flewellen EH
    JAMA; 1986 Jun; 255(24):3363-4. PubMed ID: 3712690
    [No Abstract]   [Full Text] [Related]  

  • 31. Unexplained increases in serum creatine kinase levels: its relation to malignant hyperthermia susceptibility.
    Lingaraju N; Rosenberg H
    Anesth Analg; 1991 May; 72(5):702-5. PubMed ID: 2018229
    [No Abstract]   [Full Text] [Related]  

  • 32. Malignant hyperthermia suggestive hypermetabolic syndrome at emergence from anesthesia.
    Christiaens F; Gepts E; D'Haese J; Camu F
    Acta Anaesthesiol Belg; 1995; 46(2):93-7. PubMed ID: 8714856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Williams syndrome: masseter spasm during anaesthesia.
    Patel J; Harrison MJ
    Anaesthesia; 1991 Feb; 46(2):115-6. PubMed ID: 1872423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Masseter spasm following intravenous suxamethonium: a case report.
    Barnes PK
    Br J Anaesth; 1973 Jul; 45(7):759-60. PubMed ID: 4730171
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical and laboratory aspects of malignant hyperthermia in children with special reference to creatine kinase isoenzymes (author's transl)].
    Blume H; Schmidt EW; Cayuela S; Ostheimer U; Perge V; Stankovic R; Wellstein A
    Anaesthesist; 1978 Mar; 27(3):108-14. PubMed ID: 646084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Masseter contracture and tachycardia causing termination of anesthesia.
    Burger BW; Malsch E; Mayer BW
    Anesth Prog; 1984; 31(6):257-62. PubMed ID: 6597693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathophysiology of malignant hyperthermia.
    Ording H
    Ann Fr Anesth Reanim; 1989; 8(5):411-6. PubMed ID: 2697155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum creatine kinase level as a screening test for susceptibility to malignant hyperthermia.
    Paasuke RT; Brownell AK
    JAMA; 1986 Feb; 255(6):769-71. PubMed ID: 3944979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Creatinine phosphokinase and adenylate kinase activities in skeletal muscle of malignant hyperthermia susceptible patients (author's transl)].
    Oku S; Britt BA
    Masui; 1981 Aug; 30(8):819-25. PubMed ID: 6275140
    [No Abstract]   [Full Text] [Related]  

  • 40. [Diagnosis of susceptibility to malignant hyperthermia in children].
    Krivosic-Horber R; Adnet P; Krivosic I; Reyford H
    Arch Fr Pediatr; 1990; 47(6):421-4. PubMed ID: 2403268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.